$INFU
InfuSystem Holdings, Inc

2016 Q1 Form 10-Q Financial Statement

#000119312516585767 Filed on May 10, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $18.29M $16.73M
YoY Change 9.38% -3.0%
Cost Of Revenue $3.506M $3.015M
YoY Change 16.29% 4.33%
Gross Profit $12.56M $12.09M
YoY Change 3.87% 0.11%
Gross Profit Margin 68.64% 72.28%
Selling, General & Admin $9.484M $8.712M
YoY Change 8.86% 15.18%
% of Gross Profit 75.53% 72.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.010M $100.0K
YoY Change 910.0% 0.0%
% of Gross Profit 8.04% 0.83%
Operating Expenses $12.14M $10.54M
YoY Change 15.24% 2.3%
Operating Profit $414.0K $1.552M
YoY Change -73.32% -12.61%
Interest Expense $305.0K $672.0K
YoY Change -54.61% -18.74%
% of Operating Profit 73.67% 43.3%
Other Income/Expense, Net -$285.0K -$2.252M
YoY Change -87.34% 166.82%
Pretax Income $129.0K -$700.0K
YoY Change -118.43% -175.11%
Income Tax $88.00K -$285.0K
% Of Pretax Income 68.22%
Net Earnings $41.00K -$415.0K
YoY Change -109.88% -171.18%
Net Earnings / Revenue 0.22% -2.48%
Basic Earnings Per Share $0.00 -$0.02
Diluted Earnings Per Share $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 22.55M shares 22.31M shares
Diluted Shares Outstanding 23.04M shares 22.31M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $600.0K $3.200M
YoY Change -81.25% 540.0%
Cash & Equivalents $569.0K $3.224M
Short-Term Investments
Other Short-Term Assets $1.087M $1.129M
YoY Change -3.72% 58.12%
Inventory $2.622M $1.979M
Prepaid Expenses
Receivables $15.36M $11.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $22.38M $20.08M
YoY Change 11.44% 18.11%
LONG-TERM ASSETS
Property, Plant & Equipment $2.308M $2.457M
YoY Change -6.06% 168.52%
Goodwill
YoY Change
Intangibles $31.83M $25.85M
YoY Change 23.14% 7.38%
Long-Term Investments
YoY Change
Other Assets $260.0K $206.0K
YoY Change 26.21% -13.45%
Total Long-Term Assets $77.78M $67.38M
YoY Change 15.43% 10.02%
TOTAL ASSETS
Total Short-Term Assets $22.38M $20.08M
Total Long-Term Assets $77.78M $67.38M
Total Assets $100.2M $87.47M
YoY Change 14.52% 11.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.014M $5.367M
YoY Change 49.32% 4.15%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.177M $5.537M
YoY Change -6.5% 4.37%
Total Short-Term Liabilities $15.65M $13.06M
YoY Change 19.85% 0.96%
LONG-TERM LIABILITIES
Long-Term Debt $32.43M $28.08M
YoY Change 15.5% 28.43%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $32.43M $28.08M
YoY Change 15.5% 28.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.65M $13.06M
Total Long-Term Liabilities $32.43M $28.08M
Total Liabilities $48.09M $41.14M
YoY Change 16.88% 18.22%
SHAREHOLDERS EQUITY
Retained Earnings -$39.47M -$44.12M
YoY Change -10.54% -5.08%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.08M $46.33M
YoY Change
Total Liabilities & Shareholders Equity $100.2M $87.47M
YoY Change 14.52% 11.78%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income $41.00K -$415.0K
YoY Change -109.88% -171.18%
Depreciation, Depletion And Amortization $1.010M $100.0K
YoY Change 910.0% 0.0%
Cash From Operating Activities $340.0K -$1.390M
YoY Change -124.46% 117.19%
INVESTING ACTIVITIES
Capital Expenditures -$3.270M $3.670M
YoY Change -189.1% 225.64%
Acquisitions
YoY Change
Other Investing Activities $880.0K $1.120M
YoY Change -21.43% -10.4%
Cash From Investing Activities -$2.390M -$2.550M
YoY Change -6.27% -2061.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $33.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.800M 6.650M
YoY Change -72.93% -5215.38%
NET CHANGE
Cash From Operating Activities 340.0K -1.390M
Cash From Investing Activities -2.390M -2.550M
Cash From Financing Activities 1.800M 6.650M
Net Change In Cash -250.0K 2.710M
YoY Change -109.23% -523.44%
FREE CASH FLOW
Cash From Operating Activities $340.0K -$1.390M
Capital Expenditures -$3.270M $3.670M
Free Cash Flow $3.610M -$5.060M
YoY Change -171.34% 186.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22623987 shares
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3224000
CY2016Q1 infu Medical Equipment Net
MedicalEquipmentNet
32225000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
100164000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
15653000
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22569392 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22767052 shares
CY2016Q1 us-gaap Assets
Assets
100164000
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4936000
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5301000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
22380000
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5058000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
569000
CY2016Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
11158000
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5451000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15359000
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4158000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8014000
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
7397000
CY2016Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2590000
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91543000
CY2016Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2743000
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
32433000
CY2016Q1 us-gaap Long Term Debt
LongTermDebt
37610000
CY2016Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5082000
CY2016Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
5177000
CY2016Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1087000
CY2016Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
15663000
CY2016Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31833000
CY2016Q1 us-gaap Inventory Net
InventoryNet
2622000
CY2016Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2462000
CY2016Q1 us-gaap Liabilities
Liabilities
48086000
CY2016Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6326000
CY2016Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3241000
CY2016Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7298000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
260000
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
51093000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2308000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
52078000
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
126000
CY2016Q1 infu Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
0
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2370000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39467000
CY2015Q4 us-gaap Liabilities
Liabilities
45037000
CY2016Q1 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
291000
CY2016Q1 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
19260000
CY2016Q1 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
56785000
CY2016Q1 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2426000
CY2016Q1 infu Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
126000
CY2016Q1 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
26695000
CY2016Q1 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
29799000
CY2016Q1 infu Unamortized Value Of Debt Issuance Costs Principal In Year Five
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFive
8000
CY2016Q1 infu Unamortized Value Of Debt Issuance Costs Principal In Year Four
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFour
31000
CY2016Q1 infu Unamortized Value Of Debt Issuance Costs Principal Remainder Of Fiscal Year
UnamortizedValueOfDebtIssuanceCostsPrincipalRemainderOfFiscalYear
25000
CY2016Q1 infu Unamortized Value Of Debt Issuance Costs Principal In Year Three
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearThree
31000
CY2016Q1 infu Unamortized Value Of Debt Issuance Costs Principal In Year Two
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearTwo
31000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
515000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22541890 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22739550 shares
CY2015Q4 us-gaap Assets
Assets
96315000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
20544000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4737000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
818000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
11502000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14206000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6586000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91238000
CY2015Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2743000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29750000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
34810000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5060000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
861000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31534000
CY2015Q4 us-gaap Inventory Net
InventoryNet
1916000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3641000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96315000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15287000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
251000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
51317000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
51278000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39962000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
134000
CY2015Q4 infu Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
0
CY2015Q4 infu Medical Equipment Net
MedicalEquipmentNet
30114000
CY2015Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
232000
CY2015Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
19783000
CY2015Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
53681000
CY2015Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2277000
CY2015Q4 infu Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
134000
CY2015Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
25612000
CY2015Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
27837000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2709000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5975000
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
631000
CY2015Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
100000
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.408 pure
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
16725000
CY2015Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
45980000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2252000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
CY2015Q1 us-gaap Gross Profit
GrossProfit
12089000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
10537000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-415000
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1194000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-700000
CY2015Q1 us-gaap Interest Expense
InterestExpense
672000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2552000
CY2015Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
147000
CY2015Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1599000
CY2015Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1118000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1552000
CY2015Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
15139000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6653000
CY2015Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3670000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-285000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1392000
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3015000
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1586000
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22308730 shares
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2737000
CY2015Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
39180000
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22308730 shares
CY2015Q1 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1621000
CY2015Q1 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1000000
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001337013
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-249000
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6669000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
912000
CY2016Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
100000
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1806000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23039256 shares
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
495000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1747000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
879000
CY2016Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.409 pure
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
19044000
CY2016Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
17081000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-285000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2016Q1 us-gaap Gross Profit
GrossProfit
13307000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
12143000
CY2016Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
125000
CY2016Q1 us-gaap Interest Expense
InterestExpense
305000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2390000
CY2016Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
884000
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
33000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
490718 shares
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1164000
CY2016Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
17238000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1804000
CY2016Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3274000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
384000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
337000
CY2016Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3506000
CY2016Q1 us-gaap Reductions In Other Assets Amount
ReductionsInOtherAssetsAmount
100000
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22548538 shares
CY2016Q1 dei Trading Symbol
TradingSymbol
INFU
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2815000
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
15369000
CY2016Q1 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
2231000
CY2016Q1 infu Reduction In Long Term Debt
ReductionInLongTermDebt
100000
CY2016Q1 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1500000

Files In Submission

Name View Source Status
0001193125-16-585767-index-headers.html Edgar Link pending
0001193125-16-585767-index.html Edgar Link pending
0001193125-16-585767.txt Edgar Link pending
0001193125-16-585767-xbrl.zip Edgar Link pending
d180207d10q.htm Edgar Link pending
d180207dex311.htm Edgar Link pending
d180207dex312.htm Edgar Link pending
d180207dex321.htm Edgar Link pending
d180207dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g180207txpg01.jpg Edgar Link pending
infu-20160331.xml Edgar Link completed
infu-20160331.xsd Edgar Link pending
infu-20160331_cal.xml Edgar Link unprocessable
infu-20160331_def.xml Edgar Link unprocessable
infu-20160331_lab.xml Edgar Link unprocessable
infu-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending